Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.

ABSTRACT:

Background

Routine brain imaging screening (BIS) in patients with metastatic breast cancer (BC) without neurological symptoms is currently not recommended, as no survival/quality-of-life improvements have been demonstrated. We aimed to examine physicians and patients' attitudes and perceptions toward BIS.

Methods

International cross-sectional online survey for patients and physicians, distributed from May 2023 to February 2024. Patients with BC diagnosis were deemed eligible for patients' survey completion and BC-treating physicians were invited to fill the physicians' questionnaire.

Results

A total of 529 physicians from 50 countries (80 % European) responded, mostly medical oncologists (70 %) working in academic hospitals (53 %). Most physicians request BIS (65 %),

SUBMITTER: Matos L 

PROVIDER: S-EPMC12683136 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature